Everything You Need To Know About Retatrutide in 2026 (WATCH BEFORE TAKING)

Book your free discovery call HERE: https://drjonesdc.com/yt1d Retatrutide is lately being called the "King of GLP-1s" because clinical trials show up to 24-29% weight loss. But simply calling it "stronger" misses the point. In this video,I break down the specific mechanism of the "Triple G" agonist (GLP-1, GIP, and Glucagon) and why it might be the solution for people with fatty liver, insulin resistance, and visceral fat—even if they didn't feel great on Tirzepatide, the "Appetite Paradox" (why you might feel hungrier but lose more weight), the massive reductions in liver fat, and the surprising energy boost many patients report. 📍Chapters 00:00 - Intro 01:10 - How the "Triple G" Works 02:12 - Category 1: The Appetite Paradox (Why you might feel hungry) 05:28 - How to book a Discovery Call 05:40 - Category 2: Body Composition (Visceral Fat vs. Muscle) 08:25 - Category 3: Lipids & Heart Health (41% Reduction) 10:39 - Category 4: Energy Levels & Metabolic Activation 13:06 - Category 5: Insulin Sensitivity Reset (-71% Fasting Insulin) 15:47 - The 5-Category Recap 16:45 - Verdict: Retatrutide or Tirzepatide? 17:36 Final Thoughts & Outro DISCLAIMER The content in this video is intended for educational and informational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment. Always consult with a qualified, licensed healthcare provider before beginning or modifying any treatment, medication, or wellness program discussed herein. Dr. Jones and his affiliates expressly disclaim any liability for direct or indirect loss, injury, or damage incurred as a result of reliance on the information presented. This video may discuss prescription medications, including GLP-1 receptor agonists, peptides, and other metabolic therapies, some of which may involve off-label use, compounded formulations, or investigational drugs not yet approved by the U.S. Food and Drug Administration (FDA). The inclusion of any compound—whether FDA-approved, compounded under Section 503A of the FD&C Act, or used under state-specific medical discretion—does not constitute an endorsement, promotion, or medical recommendation. The legal status of compounded medications may vary by jurisdiction and is subject to change under federal and state law, as well as FDA enforcement discretion. This content is not intended to advertise or promote any specific drug, product, or provider. Statements about potential benefits or outcomes are general in nature and have not been evaluated by the FDA unless otherwise noted. No guarantees of effectiveness or safety are made, and all therapies discussed should be considered in the context of individual medical oversight. Patient stories, testimonials, before-and-after imagery, or references to clinical results represent real cases managed by licensed professionals. Individual results vary, and outcomes are not guaranteed. Where applicable, patient names, likenesses, voices, or identifying details have been changed or anonymized in compliance with HIPAA, state privacy laws, and professional ethical guidelines. All patient media is used with written consent or has been sufficiently de-identified to meet legal standards. Footage or imagery used may depict real patients or actors and should not be interpreted as typical or universal results. By viewing this video, you acknowledge that you are voluntarily assuming full responsibility for any personal decisions made based on the content presented. This video is for general public consumption and is not intended to create a doctor-patient relationship. For personalized advice or a treatment plan, consult a licensed healthcare provider directly.